Lpl Financial LLC Acadia Pharmaceuticals Inc Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Lpl Financial LLC holds 73,413 shares of ACAD stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,413
Previous 72,407 1.39%
Holding current value
$1.38 Million
Previous $1.18 Million 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$15.14 - $19.14 $15,230 - $19,254
1,006 Added 1.39%
73,413 $1.13 Million
Q2 2024

Aug 07, 2024
BUY
$14.62 - $18.42 $182,969 - $230,526
12,515 Added 20.9%
72,407 $1.18 Million
Q1 2024

May 10, 2024
SELL
$17.79 - $30.86 $56,536 - $98,073
-3,178 Reduced 5.04%
59,892 $1.11 Million
Q4 2023

Feb 14, 2024
BUY
$20.78 - $31.77 $100,325 - $153,385
4,828 Added 8.29%
63,070 $1.97 Million
Q3 2023

Nov 13, 2023
BUY
$20.84 - $33.47 $121,914 - $195,799
5,850 Added 11.17%
58,242 $1.21 Million
Q2 2023

Jul 31, 2023
BUY
$17.8 - $25.65 $101,602 - $146,410
5,708 Added 12.23%
52,392 $1.25 Million
Q1 2023

May 10, 2023
BUY
$16.32 - $20.92 $148,952 - $190,936
9,127 Added 24.3%
46,684 $878,000
Q4 2022

Feb 07, 2023
SELL
$14.2 - $18.63 $2,243 - $2,943
-158 Reduced 0.42%
37,557 $597,000
Q3 2022

Nov 14, 2022
SELL
$14.11 - $18.27 $13,263 - $17,173
-940 Reduced 2.43%
37,715 $617,000
Q2 2022

Aug 12, 2022
SELL
$13.01 - $27.22 $8,950 - $18,727
-688 Reduced 1.75%
38,655 $545,000
Q1 2022

May 16, 2022
BUY
$20.94 - $27.5 $28,310 - $37,180
1,352 Added 3.56%
39,343 $953,000
Q4 2021

Feb 14, 2022
SELL
$16.79 - $27.09 $229,636 - $370,509
-13,677 Reduced 26.47%
37,991 $887,000
Q3 2021

Nov 15, 2021
BUY
$15.78 - $24.77 $72,745 - $114,189
4,610 Added 9.8%
51,668 $858,000
Q2 2021

Aug 13, 2021
BUY
$19.4 - $27.42 $137,604 - $194,490
7,093 Added 17.75%
47,058 $1.15 Million
Q1 2021

May 14, 2021
SELL
$25.02 - $54.99 $35,928 - $78,965
-1,436 Reduced 3.47%
39,965 $1.03 Million
Q4 2020

Feb 12, 2021
BUY
$41.04 - $56.79 $171,013 - $236,643
4,167 Added 11.19%
41,401 $2.21 Million
Q3 2020

Nov 09, 2020
BUY
$36.42 - $57.0 $15,223 - $23,826
418 Added 1.14%
37,234 $1.54 Million
Q2 2020

Aug 13, 2020
BUY
$39.26 - $52.73 $27,992 - $37,596
713 Added 1.97%
36,816 $1.78 Million
Q1 2020

May 14, 2020
SELL
$31.65 - $46.87 $647,685 - $959,147
-20,464 Reduced 36.18%
36,103 $1.53 Million
Q4 2019

Feb 14, 2020
BUY
$36.21 - $51.4 $120,615 - $171,213
3,331 Added 6.26%
56,567 $2.42 Million
Q3 2019

Nov 13, 2019
SELL
$22.22 - $44.01 $1.56 Million - $3.1 Million
-70,344 Reduced 56.92%
53,236 $1.92 Million
Q2 2019

Aug 09, 2019
BUY
$23.32 - $28.12 $106,922 - $128,930
4,585 Added 3.85%
123,580 $3.3 Million
Q1 2019

May 08, 2019
SELL
$16.17 - $27.38 $34,118 - $57,771
-2,110 Reduced 1.74%
118,995 $3.2 Million
Q4 2018

Feb 07, 2019
SELL
$14.32 - $22.92 $138,374 - $221,475
-9,663 Reduced 7.39%
121,105 $1.96 Million
Q3 2018

Nov 14, 2018
SELL
$13.03 - $21.81 $130,117 - $217,794
-9,986 Reduced 7.09%
130,768 $2.72 Million
Q2 2018

Aug 14, 2018
SELL
$15.07 - $22.34 $137,890 - $204,411
-9,150 Reduced 6.1%
140,754 $2.15 Million
Q1 2018

May 15, 2018
SELL
$22.47 - $32.33 $197,016 - $283,469
-8,768 Reduced 5.53%
149,904 $3.37 Million
Q4 2017

Feb 14, 2018
BUY
$26.84 - $39.14 $1.76 Million - $2.56 Million
65,517 Added 70.33%
158,672 $4.78 Million
Q3 2017

Nov 14, 2017
BUY
$29.49 - $38.37 $35,388 - $46,044
1,200 Added 1.3%
93,155 $3.51 Million
Q2 2017

Aug 14, 2017
BUY
N/A
91,955
91,955 $2.57 Million

Others Institutions Holding ACAD

# of Institutions
283
Shares Held
158M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.03B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email